Are Target Urate and Remission Possible in Severe Gout? A Five-year Cohort Study

Alvarado-de la Barrera Claudia; Omar Lopez-Lopez Carlos; Alvarez-Hernandez Everardo; Pelaez-Ballestas Ingris; Gomez-Ruiz Citlallyc; Burgos-Vargas Ruben; Vazquez-Mellado Janitzia

首页> 外文期刊>The Journal of rheumatology >Are Target Urate and Remission Possible in Severe Gout? A Five-year Cohort Study

【24h】

Are Target Urate and Remission Possible in Severe Gout? A Five-year Cohort Study

机译：在严重的痛风中是目标呼吸和缓解吗？一个五年的队列研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objective. Determine the proportion of patients achieving target serum urate (SU), defined as < 6 mg/dl for patients with non-severe gout and < 5 mg/dl for patients with severe gout, as well as the proportion of patients achieving remission after 5 years of followup.

机译：客观的。确定患者患者患者的比例，定义为具有严重痛风患者的非严重痛风和<5mg / dl的患者的<6mg / dL，以及5岁以后实现缓解的患者的比例多年的后续行动。

著录项

来源
《The Journal of rheumatology》 |2020年第1期|共8页
作者
Alvarado-de la Barrera Claudia; Omar Lopez-Lopez Carlos; Alvarez-Hernandez Everardo; Pelaez-Ballestas Ingris; Gomez-Ruiz Citlallyc; Burgos-Vargas Ruben; Vazquez-Mellado Janitzia;
展开▼
作者单位

Inst Nacl Enfermedades Resp Ismael Cosio Villegas Direcc Invest Mexico City DF Mexico;

Hosp Gen Mexico City Serv Med Fis &

Rehabil Unidad 402 Mexico City DF Mexico;

Hosp Gen Mexico City Serv Reumatol Unidad 404 Dr Balmis 148 Mexico City 06720 DF Mexico;

Hosp Gen Mexico City Serv Reumatol Unidad 404 Dr Balmis 148 Mexico City 06720 DF Mexico;

Hosp Gen Mexico City Serv Reumatol Unidad 404 Dr Balmis 148 Mexico City 06720 DF Mexico;

Hosp Gen Mexico City Serv Med Fis &

Rehabil Unidad 402 Mexico City DF Mexico;

Hosp Gen Mexico City Serv Reumatol Unidad 404 Dr Balmis 148 Mexico City 06720 DF Mexico;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
TARGET URATE; REMISSION; GOUT; SEVERE GOUT; URIC ACID;

机译：目标淫乱;缓解;痛风;严重痛风;尿酸;

相似文献

外文文献
中文文献
专利

1. Are Target Urate and Remission Possible in Severe Gout? A Five-year Cohort Study [J] . Alvarado-de la Barrera Claudia, Omar Lopez-Lopez Carlos, Alvarez-Hernandez Everardo, The Journal of rheumatology . 2020,第1期

机译：在严重的痛风中是目标呼吸和缓解吗？一个五年的队列研究
2. Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort [J] . Nan Liang, Mingshu Sun, Ruixia Sun, Arthritis research & therapy. . 2019,第1期

机译：基线尿酸盐水平和肾功能可预测使用低剂量非布索坦和苯溴马隆降低尿酸盐治疗的结果：一项在中国原发性痛风人群中的前瞻性，随机对照研究
3. Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Affairs Gout Cohort [J] . Singh Jasvinder A., Yang Shuo, Saag Kenneth G. The Journal of rheumatology . 2020,第3期

机译：影响美国退休队痛风队伍促进含有Allopurinol在达到靶血清血清呼气的因素
4. ~(213)Bi-DOTATOC receptor targeted alpha-radionuclide therapy induces remission in neuroendocrine tumors refractory to beta-radiation - a first in human study [C] . Giesel FL, Kratochwil C, Bruchertseifer F, 8th International Conference on Isotopes 2014 . 2014

机译：〜（213）Bi-DOTATOC受体靶向的α-放射性核素疗法可诱导难于β辐射的神经内分泌肿瘤缓解-这是人类研究中的首次
5. Characteristics of Patients with Severe and Non-Severe Permanent Tooth Trauma Presenting to a Pediatric Hospital Emergency Department Over a Five-year Period [D] . Sekhon, Poonampreet 2019

机译：五年期间向儿科医院急诊科就诊的重度和非重度永久性牙齿创伤患者的特征
6. Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective randomized controlled study in a Chinese primary gout cohort [O] . Nan Liang, Mingshu Sun, Ruixia Sun, 2019

机译：基线尿酸水平和肾功能可预测使用低剂量非布索坦和苯溴马隆降低尿酸治疗的结果：一项针对中国原发性痛风人群的前瞻性随机对照研究
7. POS0139 TWO-YEAR REDUCTION OF URATE LOAD IN DUAL-ENERGY CT DURING A TREAT-TO-TARGET APPROACH IN GOUT PATIENTS: RESULTS FROM A LONGITUDINAL STUDY (NOR-GOUT) [O] . T. Uhlig, T. Eskild, L. F. Karoliussen, 2021

机译：POS0139在痛风患者的治疗到目标方法中双能CT的两年减少双能CT：纵向研究的结果（NOR-GOUT）

Are Target Urate and Remission Possible in Severe Gout? A Five-year Cohort Study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅